143 related articles for article (PubMed ID: 29522538)
1. Exome-wide somatic mutation characterization of small bowel adenocarcinoma.
Hänninen UA; Katainen R; Tanskanen T; Plaketti RM; Laine R; Hamberg J; Ristimäki A; Pukkala E; Taipale M; Mecklin JP; Forsström LM; Pitkänen E; Palin K; Välimäki N; Mäkinen N; Aaltonen LA
PLoS Genet; 2018 Mar; 14(3):e1007200. PubMed ID: 29522538
[TBL] [Abstract][Full Text] [Related]
2. Genomic Profiling of Small-Bowel Adenocarcinoma.
Schrock AB; Devoe CE; McWilliams R; Sun J; Aparicio T; Stephens PJ; Ross JS; Wilson R; Miller VA; Ali SM; Overman MJ
JAMA Oncol; 2017 Nov; 3(11):1546-1553. PubMed ID: 28617917
[TBL] [Abstract][Full Text] [Related]
3. Small Bowel Adenocarcinoma.
Aparicio T; Zaanan A; Mary F; Afchain P; Manfredi S; Evans TR
Gastroenterol Clin North Am; 2016 Sep; 45(3):447-57. PubMed ID: 27546842
[TBL] [Abstract][Full Text] [Related]
4. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.
Dulak AM; Stojanov P; Peng S; Lawrence MS; Fox C; Stewart C; Bandla S; Imamura Y; Schumacher SE; Shefler E; McKenna A; Carter SL; Cibulskis K; Sivachenko A; Saksena G; Voet D; Ramos AH; Auclair D; Thompson K; Sougnez C; Onofrio RC; Guiducci C; Beroukhim R; Zhou Z; Lin L; Lin J; Reddy R; Chang A; Landrenau R; Pennathur A; Ogino S; Luketich JD; Golub TR; Gabriel SB; Lander ES; Beer DG; Godfrey TE; Getz G; Bass AJ
Nat Genet; 2013 May; 45(5):478-86. PubMed ID: 23525077
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive genomic profiling of small bowel adenocarcinoma by tissue and plasma biopsy.
Yu D; Wang J; Zheng B; Yuan M; Gu D; Chen R; Chen X
Genomics; 2024 Jan; 116(1):110766. PubMed ID: 38141930
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of Chinese patients with small bowel adenocarcinoma.
Jin B; Lv B; Yan Z; Li W; Song H; Cui H; Liu Y; Zhong B; Shen X; Li X; Zhang B; Chen S; Zheng W; Liu J; Luo F; Luo Z
Clin Transl Oncol; 2024 Mar; ():. PubMed ID: 38512449
[TBL] [Abstract][Full Text] [Related]
7. Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas: next-generation sequencing and machine learning for full tumor exome analysis.
Shatalov PA; Falaleeva NA; Bykova EA; Korostin DO; Belova VA; Zabolotneva AA; Shinkarkina AP; Gorbachev AY; Potievskiy MB; Surkova VS; Khailova ZV; Kulemin NA; Baranovskii D; Kostin AA; Kaprin AD; Shegai PV
Oncotarget; 2024 Feb; 15():91-103. PubMed ID: 38329726
[TBL] [Abstract][Full Text] [Related]
8. Commonalities and differences in the mutational signature and somatic driver mutation landscape across solid and hollow viscus organs.
Ng AS; Chan DKH
Oncogene; 2023 Sep; 42(37):2713-2724. PubMed ID: 37573406
[TBL] [Abstract][Full Text] [Related]
9. A Clinicopathologic Comparison Between Early-Onset and Late-Onset Small Bowel Adenocarcinoma: A Multicenter International Study.
Arpa G; Vanoli A; Antoci F; Lenti MV; Di Sabatino A;
Am J Gastroenterol; 2024 Jan; ():. PubMed ID: 37966091
[TBL] [Abstract][Full Text] [Related]
10. DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway.
Adam L; San Lucas FA; Fowler R; Yu Y; Wu W; Liu Y; Wang H; Menter D; Tetzlaff MT; Ensor J; Manyam G; Arold ST; Huff C; Kopetz S; Scheet P; Overman MJ
Clin Cancer Res; 2019 Jan; 25(2):641-651. PubMed ID: 30352910
[TBL] [Abstract][Full Text] [Related]
11. Whole-exome sequencing identifies germline mutation in
Nordfors K; Haapasalo J; Afyounian E; Tuominen J; Annala M; Häyrynen S; Karhu R; Helén P; Lohi O; Nykter M; Haapasalo H; Granberg KJ
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29602769
[TBL] [Abstract][Full Text] [Related]
12. Characterization and Clinical Outcomes of DNA Mismatch Repair-deficient Small Bowel Adenocarcinoma.
Latham A; Shia J; Patel Z; Reidy-Lagunes DL; Segal NH; Yaeger R; Ganesh K; Connell L; Kemeny NE; Kelsen DP; Hechtman JF; Nash GM; Paty PB; Zehir A; Tkachuk KA; Sheikh R; Markowitz AJ; Mandelker D; Offit K; Berger MF; Cercek A; Garcia-Aguilar J; Saltz LB; Weiser MR; Stadler ZK
Clin Cancer Res; 2021 Mar; 27(5):1429-1437. PubMed ID: 33199489
[TBL] [Abstract][Full Text] [Related]
13. Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma.
Quaas A; Heydt C; Waldschmidt D; Alakus H; Zander T; Goeser T; Kasper P; Bruns C; Brunn A; Roth W; Hartmann N; Bunck A; Schmidt M; Buettner R; Merkelbach-Bruse S
BMC Gastroenterol; 2019 Feb; 19(1):21. PubMed ID: 30717682
[TBL] [Abstract][Full Text] [Related]
14. Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer.
Lin A; Zhang H; Hu X; Chen X; Wu G; Luo P; Zhang J
Pharmacol Res; 2020 Sep; 159():105028. PubMed ID: 32569820
[TBL] [Abstract][Full Text] [Related]
15. Small Bowel Adenocarcinoma: Etiology, Presentation, and Molecular Alterations.
Pedersen KS; Raghav K; Overman MJ
J Natl Compr Canc Netw; 2019 Sep; 17(9):1135-1141. PubMed ID: 31487680
[TBL] [Abstract][Full Text] [Related]
16. Systematic Functional Annotation of Somatic Mutations in Cancer.
Ng PK; Li J; Jeong KJ; Shao S; Chen H; Tsang YH; Sengupta S; Wang Z; Bhavana VH; Tran R; Soewito S; Minussi DC; Moreno D; Kong K; Dogruluk T; Lu H; Gao J; Tokheim C; Zhou DC; Johnson AM; Zeng J; Ip CKM; Ju Z; Wester M; Yu S; Li Y; Vellano CP; Schultz N; Karchin R; Ding L; Lu Y; Cheung LWT; Chen K; Shaw KR; Meric-Bernstam F; Scott KL; Yi S; Sahni N; Liang H; Mills GB
Cancer Cell; 2018 Mar; 33(3):450-462.e10. PubMed ID: 29533785
[TBL] [Abstract][Full Text] [Related]
17. Molecular Landscape and Association With Crohn Disease of Poorly Cohesive Carcinomas of the Nonampullary Small Bowel.
Tedaldi G; Guerini C; Angeli D; Furlan D; Libera L; Lenti MV; Grillo F; Fassan M; Solcia E; Sessa F; Paulli M; Di Sabatino A; Ulivi P; Vanoli A
Am J Clin Pathol; 2023 Apr; 159(4):315-324. PubMed ID: 36812376
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma.
Pan H; Cheng H; Wang H; Ge W; Yuan M; Jiang S; Wan X; Dong Y; Liu Z; Zhao R; Fang Y; Lou F; Cao S; Han W
Cancer Sci; 2021 Nov; 112(11):4758-4771. PubMed ID: 34449929
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.
Marabelle A; Le DT; Ascierto PA; Di Giacomo AM; De Jesus-Acosta A; Delord JP; Geva R; Gottfried M; Penel N; Hansen AR; Piha-Paul SA; Doi T; Gao B; Chung HC; Lopez-Martin J; Bang YJ; Frommer RS; Shah M; Ghori R; Joe AK; Pruitt SK; Diaz LA
J Clin Oncol; 2020 Jan; 38(1):1-10. PubMed ID: 31682550
[TBL] [Abstract][Full Text] [Related]
20. Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; Venook AP; Al-Hawary MM; Arain MA; Chen YJ; Ciombor KK; Cohen SA; Cooper HS; Deming DA; Garrido-Laguna I; Grem JL; Hoffe SE; Hubbard J; Hunt S; Kamel A; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen KS; Saltz LB; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Johnson-Chilla A; Gregory KM; Gurski LA
J Natl Compr Canc Netw; 2019 Sep; 17(9):1109-1133. PubMed ID: 31487687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
